(2008) The x c cystine/glutamate antiporter: a potential target for therapy of cancer and other diseases, J
60 capsules per bottle
In controlled laboratory and pre-clinical settings, Melanotan 1 is studied across MC1R receptor pharmacology, melanogenesis biology, photoprotection, skin immunology, anti-inflammatory biology, and comparative melanocortin agonist research applications: MT-1 is the primary reference agonist for MC1R pharmacology , used to characterise receptor binding kinetics and affinity, Gs-coupled cAMP-PKA signal transduction downstream of MC1R engagement, MITF transcription factor activation and downstream melanogenesis gene upregulation, tyrosinase and TYRP1/TYRP2 enzyme expression and activity, and melanosome biogenesis and transfer to keratinocytes
By contrast, peptide GLP-1RA COM patents are built on a different logic: claims that cover the precise peptide sequence and its specific modifications, with limited genus scope because the SAR around peptide modifications is exquisitely position-specific